These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 38104989

  • 1. LMNA::NTRK1 Fusion-positive Leiomyosarcoma: Discrepancy between DNA-based Comprehensive Genomic Profiling and RNA Sequencing.
    Suzuki N, Idogawa M, Emori M, Murase K, Arihara Y, Nakamura H, Usami M, Kubo T, Kinoshita I, Sugita S, Tokino T, Hasegawa T, Sakurai A, Takada K.
    Intern Med; 2024 Aug 01; 63(15):2215-2219. PubMed ID: 38104989
    [Abstract] [Full Text] [Related]

  • 2. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun 01; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 3. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H, Xue X, Ding H, Ou Q, Wu X, Nagasaka M, Shao YW, Hu X, Ou SI.
    Clin Lung Cancer; 2020 May 01; 21(3):247-254. PubMed ID: 31761448
    [Abstract] [Full Text] [Related]

  • 4. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N, Hayashi T, Niizuma H, Kikuta K, Imanishi J, Endo M, Ikeuchi H, Sasa K, Sano K, Hirabayashi K, Takagi T, Ishijima M, Kato S, Kohsaka S, Saito T, Suehara Y.
    Clin Orthop Relat Res; 2024 Mar 01; 482(3):549-563. PubMed ID: 38014853
    [Abstract] [Full Text] [Related]

  • 5. Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.
    So YK, Chow C, To KF, Chan JKC, Cheuk W.
    Int J Surg Pathol; 2020 Aug 01; 28(5):574-578. PubMed ID: 32050835
    [Abstract] [Full Text] [Related]

  • 6. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.
    Zhou N, Schäfer R, Li T, Fang M, Liu L.
    BMC Cancer; 2018 Aug 22; 18(1):842. PubMed ID: 30134855
    [Abstract] [Full Text] [Related]

  • 7. Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib.
    Bender J, Anderson B, Bloom DA, Rabah R, McDougall R, Vats P, Mody R.
    Cold Spring Harb Mol Case Stud; 2019 Feb 22; 5(1):. PubMed ID: 30709876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY, Choi C, Shin E, Lee JH, Kwon CH, Jo HJ, Kim HR, Kim HS, Oh N, Lee JS, Park OK, Park E, Park J, Shin JY, Kim JI, Seo JS, Park HD, Park J.
    Oncotarget; 2016 Feb 16; 7(7):8399-412. PubMed ID: 26716414
    [Abstract] [Full Text] [Related]

  • 10. LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.
    Panse G, Reisenbichler E, Snuderl M, Wang WL, Laskin W, Jour G.
    J Cutan Pathol; 2021 Feb 16; 48(2):290-294. PubMed ID: 32519338
    [Abstract] [Full Text] [Related]

  • 11. Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
    Mack PC, Keller-Evans RB, Li G, Lofgren KT, Schrock AB, Trabucco SE, Allen JM, Tolba K, Oxnard GR, Huang RSP.
    Oncologist; 2024 Aug 05; 29(8):e984-e996. PubMed ID: 38401173
    [Abstract] [Full Text] [Related]

  • 12. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y, Kohsaka S, Hayashi T, Akaike K, Kurisaki-Arakawa A, Sato S, Kobayashi E, Mizuno S, Ueno T, Morii T, Okuma T, Kurihara T, Hasegawa N, Sano K, Sasa K, Okubo T, Kim Y, Mano H, Saito T.
    Clin Orthop Relat Res; 2021 Apr 01; 479(4):838-852. PubMed ID: 33196586
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.
    J Natl Cancer Inst; 2016 Jan 01; 108(1):. PubMed ID: 26563355
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.
    Nakata E, Osone T, Ogawa T, Taguchi T, Hattori K, Kohsaka S.
    Cancer Med; 2024 Jun 01; 13(12):e7351. PubMed ID: 38925616
    [Abstract] [Full Text] [Related]

  • 15. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb 01; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 16. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb 01; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 17. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
    Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF.
    Mod Pathol; 2020 Jan 01; 33(1):38-46. PubMed ID: 31375766
    [Abstract] [Full Text] [Related]

  • 18. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL, Lockwood CM, Albert CM, Tsuchiya K, Hawkins DS, Rudzinski ER.
    Pediatr Dev Pathol; 2018 Jan 01; 21(1):68-78. PubMed ID: 28683589
    [Abstract] [Full Text] [Related]

  • 19. The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B-NTRK1 fusion.
    Shinozaki-Ushiku A, Ishikawa S, Komura D, Seto Y, Aburatani H, Ushiku T.
    Gastric Cancer; 2020 Sep 01; 23(5):944-947. PubMed ID: 32189226
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.
    Dong K, Yin L, Wang Y, Jia L, Diao X, Huang X, Zhou L, Lin D, Sun Y.
    Hum Pathol; 2024 Jun 01; 148():87-92. PubMed ID: 38653403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.